SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Press Releases
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 5, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 4, 2024
 · 
2 min read
Press Releases
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 24, 2024
 · 
4 min read
Press Releases
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
October 10, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
 · 
2 min read
Press Releases
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
 · 
1 min read
Press Releases
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
 · 
7 min read
Press Releases
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
July 30, 2024
 · 
10 min read
Press Releases
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
July 25, 2024
 · 
1 min read
Load More
JOBS